Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current Deferred Tax LiabilityOther Accumulated ExpensesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Argan (AGX) Receivables (2016 - 2025)

Argan's Receivables history spans 15 years, with the latest figure at $208.8 million for Q4 2025.

  • For Q4 2025, Receivables rose 18.44% year-over-year to $208.8 million; the TTM value through Oct 2025 reached $208.8 million, up 18.44%, while the annual FY2025 figure was $204.2 million, 113.83% up from the prior year.
  • Receivables for Q4 2025 was $208.8 million at Argan, up from $202.9 million in the prior quarter.
  • Across five years, Receivables topped out at $208.8 million in Q4 2025 and bottomed at $28.0 million in Q2 2021.
  • The 5-year median for Receivables is $71.7 million (2021), against an average of $95.8 million.
  • The largest annual shift saw Receivables tumbled 51.0% in 2022 before it soared 134.96% in 2023.
  • A 5-year view of Receivables shows it stood at $45.7 million in 2021, then increased by 8.2% to $49.4 million in 2022, then skyrocketed by 52.3% to $75.3 million in 2023, then surged by 134.06% to $176.3 million in 2024, then grew by 18.44% to $208.8 million in 2025.
  • Per Business Quant, the three most recent readings for AGX's Receivables are $208.8 million (Q4 2025), $202.9 million (Q3 2025), and $136.9 million (Q2 2025).